Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II trial of CC 292 in patients with cancer.

Trial Profile

Phase II trial of CC 292 in patients with cancer.

Phase of Trial: Phase II

Latest Information Update: 17 Jan 2013

At a glance

  • Drugs Spebrutinib (Primary)
  • Indications Cancer; Haematological malignancies; Lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top